MONTERA, ROBERTO
 Distribuzione geografica
Continente #
AS - Asia 4.983
NA - Nord America 2.221
EU - Europa 775
SA - Sud America 254
AF - Africa 36
Continente sconosciuto - Info sul continente non disponibili 35
OC - Oceania 14
Totale 8.318
Nazione #
SG - Singapore 3.750
US - Stati Uniti d'America 2.103
CN - Cina 572
IT - Italia 356
HK - Hong Kong 301
BR - Brasile 154
GB - Regno Unito 123
VN - Vietnam 97
FR - Francia 96
BD - Bangladesh 73
DE - Germania 64
CA - Canada 63
IN - India 63
MX - Messico 33
AR - Argentina 28
NL - Olanda 23
CZ - Repubblica Ceca 21
CO - Colombia 17
EC - Ecuador 17
ID - Indonesia 16
TR - Turchia 15
AU - Australia 13
IQ - Iraq 13
CL - Cile 11
SA - Arabia Saudita 11
ZA - Sudafrica 11
JP - Giappone 10
MY - Malesia 9
RU - Federazione Russa 9
FI - Finlandia 8
UA - Ucraina 8
VE - Venezuela 8
EE - Estonia 7
PH - Filippine 7
PL - Polonia 7
SE - Svezia 7
PY - Paraguay 6
UY - Uruguay 6
AE - Emirati Arabi Uniti 5
AZ - Azerbaigian 5
ES - Italia 5
MD - Moldavia 5
NP - Nepal 5
PK - Pakistan 5
AT - Austria 4
EG - Egitto 4
HN - Honduras 4
JM - Giamaica 4
RS - Serbia 4
SV - El Salvador 4
TW - Taiwan 4
BO - Bolivia 3
DZ - Algeria 3
KE - Kenya 3
KW - Kuwait 3
KZ - Kazakistan 3
LT - Lituania 3
MA - Marocco 3
NO - Norvegia 3
PE - Perù 3
SK - Slovacchia (Repubblica Slovacca) 3
TH - Thailandia 3
AO - Angola 2
BE - Belgio 2
CH - Svizzera 2
DO - Repubblica Dominicana 2
GR - Grecia 2
HU - Ungheria 2
IE - Irlanda 2
IL - Israele 2
KG - Kirghizistan 2
KR - Corea 2
LB - Libano 2
MK - Macedonia 2
NG - Nigeria 2
PT - Portogallo 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
BY - Bielorussia 1
CU - Cuba 1
CY - Cipro 1
DJ - Gibuti 1
FK - Isole Falkland (Malvinas) 1
GD - Grenada 1
GN - Guinea 1
GT - Guatemala 1
IR - Iran 1
LR - Liberia 1
LV - Lettonia 1
ML - Mali 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PR - Porto Rico 1
RE - Reunion 1
Totale 8.281
Città #
San Jose 528
Ashburn 466
Singapore 385
Hong Kong 296
Rome 239
Hefei 177
Beijing 159
Santa Clara 115
Council Bluffs 110
Boardman 95
London 92
Columbus 89
Lauterbourg 75
Shanghai 57
Dallas 42
Ho Chi Minh City 38
Los Angeles 36
Munich 32
San Francisco 29
São Paulo 29
Phoenix 24
Montreal 23
Brno 21
Buffalo 21
New York 21
Hanoi 20
Pune 19
Toronto 17
Washington 17
Milan 16
Mexico City 14
Seattle 14
Amsterdam 13
Secaucus 11
Brooklyn 10
Chicago 10
Bogotá 9
Grumo Nevano 9
Sorab 8
Santiago 7
The Dalles 7
Tokyo 7
Warsaw 7
Canberra 6
Coral Springs 6
Dhaka 6
Frankfurt am Main 6
Naples 6
Paris 6
Quito 6
Rio de Janeiro 6
Boston 5
Guayaquil 5
Johannesburg 5
Kuala Lumpur 5
Las Vegas 5
Montevideo 5
Orem 5
Stockholm 5
Asunción 4
Catania 4
Da Nang 4
Guangzhou 4
Medellín 4
New Delhi 4
Newark 4
Philadelphia 4
Poplar 4
Ribeirão Preto 4
Riyadh 4
Salt Lake City 4
Temecula 4
Turku 4
Atlanta 3
Baghdad 3
Baku 3
Cairo 3
Caracas 3
Charlotte 3
Chattanooga 3
Chennai 3
City of London 3
Cusano Milanino 3
Dammam 3
Des Moines 3
Dubai 3
Helsinki 3
Hyderabad 3
Jacksonville 3
Jeddah 3
Karbala 3
Kirkuk 3
Kuwait City 3
Louisville 3
Manaus 3
Melbourne 3
Mysore 3
Nairobi 3
Oklahoma City 3
Quezon City 3
Totale 3.639
Nome #
Efficacy of termoablative fractional CO2 laser (Monnalisa Touch) in stress urinary incontinence 276
Feasibility and efficacy of Letrozole in heavily pre-treated patients with relapsed ovarian cancer not eligible for further chemotherapy cycles 268
Intravesical Instillations of Hyaluronic Acid as First-Line Treatment in Patients with Interstitial Cystitis/Bladder Pain Syndrome: Use, Efficacy and Effects on Quality of Life 252
A randomized controlled trial comparing four versus six courses of adjuvant platinum-based chemotherapy in locally advanced cervical cancer patients previously treated with neo-adjuvant chemotherapy plus radical surgery 248
Assessment of quality of life and urinary and sexual function after radical hysterectomy in long-term cervical cancer survivors 241
Feasibility of the use of novel matrix hemostatic sealant (FloSeal) to achieve hemostasis during laparoscopic excision of endometrioma 227
Does HE4 have a role as biomarker in the recurrence of ovarian cancer? 227
Anterior colporrhaphy plus inside-out tension-free vaginal tape for associated stress urinary incontinence and cystocele: 10-year follow up results 220
Antiangiogenics and immunotherapies in cervical cancer: an update and future's view 220
Does HE4 have a role in the recurrence of ovarian cancer? 213
Chemotherapy as adjuvant treatment for intermediate-high risk early-stage endometrial cancer a pilot study 205
Can HE4 predict platinum response during first-line chemotherapy in ovarian cancer? 203
A critical review on HE4 performance in endometrial cancer: where are we now? 152
Early Mini-Invasive Treatment of Persistent Cervical Dysplasia: Clinical Outcome and Psycho-Relational Impact 148
Role of Protopine and Nuciferine in the Management of Nocturia, Urgency, and Dysuria in Pre- and Postmenopausal Women: A Prospective Pilot Study 143
An ultra-miniinvasive treatment for stress urinary incontinence in complicated older patients 136
Effectiveness of human epididymis protein 4 (HE4) as predictor of response to first line platinum based chemotherapy 131
Bladder function after laparoscopic nerve-sparing radical hysterectomy 131
A new type of absorbable barbed suture for use in laparoscopic myomectomy 130
A gastrointestinal stromal tumor presenting as a pelvic mass: A case report 126
Adjuvant chemotherapy after primary treatments for cervical cancer: a critical point of view and review of the literature 126
Does Extensive Upper Abdomen Surgery During Primary Cytoreduction Impact on Long-term Quality of Life? 125
Aortic lymphadenectomy in cervical cancer: Anatomy, classification and technique 123
C-reactive protein "at first sight": Standard postoperative trend in gynecological surgery and a comparative analysis with white blood cell levels 121
Implementing the Risk of Endometrial Malignancy Algorithm (REM) adding obesity as a predictive factor: Results of REM-B in a single-center survey 121
Neoadjuvant chemotherapy plus radical surgery followed by chemotherapy in locally advanced cervical cancer 119
Long-term follow-up of bulking agents for stress urinary incontinence in older patients 116
The use of sealing hemostat patch (HEMOPATCH®) in laparotomic myomectomy: a prospective case-control study 115
Pelvic-cutaneous fistula after retropubic vaginal tape placement 106
The Role of TAP/RS Block in Minor Gynecologic Laparoscopic Surgery: A Randomized Clinical Trial 105
ECONOMIC IMPACT AMONG FAMILY CAREGIVERS OF ADVANCED OVARIAN CANCER PATIENTS 99
The Role of HE4, a Novel Biomarker, in Predicting Optimal Cytoreduction After Neoadjuvant Chemotherapy in Advanced Ovarian Cancer 89
Can the preoperative HE4 level predict optimal cytoreduction in patients with advanced ovarian carcinoma? 89
Old Issues and New Perspectives on Endometrial Cancer Therapy: How Molecular Characteristics Are Changing the Therapeutic Pathway 88
Ureteral injuries management in gynaecologic surgery: the role of the conservative approach 84
Further insight into prognostic factors in endometrial cancer: the new serum biomarker HE4 79
Influence of pneumoperitoneum pressure on surgical field during robotic and laparoscopic surgery: a comparative study 77
Sentinel lymph node in cervical cancer: a literature review on the use of conservative surgery techniques 71
Serous Tubal Intraepithelial Carcinoma (STIC): A Review of the Literature on the Incidence at the Time of Prophylactic Surgery 69
The role of peritoneal lavage in benign gynecologic laparoscopic surgery 68
Ovarian cancer relapse: From the latest scientific evidence to the best practice 64
The True Impact of Voiding Dysfunctions after Transobturator Sub-Urethral Tape Procedures: A Systematic Review of Literature 64
Efficacy of fractional CO2 laser treatment in postmenopausal women with genitourinary syndrome: a multicenter study 64
Role of human epididymis protein 4 (HE4) in detecting recurrence in CA125 negative ovarian cancer patients 63
Quality of life in platinum-sensitive recurrent ovarian cancer: chemotherapy versus surgery plus chemotherapy 63
Surgical primary treatment of stage IVA cervical cancer: A multicentre retrospective study 62
PROGNOSTIC FACTORS AND BYOCHEMISTRY IN PATIENTS WITH OVARIAN CANCER: A NEW CLINICAL MODEL OF PREDICTION 59
METODO PER LA DETERMINAZIONE DI UN INDICE PREDITTIVO DEL RISCHIO DI TUMORE DELL’ENDOMETRIO 59
REM (Risk of Endometrial Malignancy): a proposal for a new scoring system to evaluate risk of endometrial malignancy 59
The role of novel biomarker HE4 in the diagnosis, prognosis and follow-up of ovarian cancer: a systematic review 58
Sacral neuromodulation after stabilization of L2-S1 vertebrae with metallic fixation devices: is it feasible? 58
Tension-free vaginal tape versus transobturator suburethral tape: Five-year follow-up results of a prospective, randomised trial 57
Utility of tumor marker HE4 as prognostic factor in endometrial cancer: a single-center controlled study 57
Effectiveness of CO2 laser on urogenital syndrome in women with a previous gynecological neoplasia: a multicentric study 55
Ten years of HPV vaccines: State of art and controversies 55
Ovarian cancer recurrence and early detection: may HE4 play a key role in this open challenge? A systematic review of literature 54
Real-time infrared thermography for ureter detection during hysterectomy 54
Continuous wound infusion as a valid alternative to tap block for postoperative analgesia after abdominal hysterectomy: A randomized controlled trial 53
Update on lymphadenectomy in early and advanced ovarian cancer 53
The role of novel biomarker HE4 in endometrial cancer: a case control prospective study 51
The use of novel hemostatic sealant (Tisseel (R)) in laparoscopic myomectomy: a case-control study 50
Role of paroxetine in the management of hot flashes in gynecological cancer survivors: Results of the first randomized single-center controlled trial 50
The effects of giving patients verbal or written pre-operative information in gynecologic oncology surgery: a randomized study and the medical-legal point of view 50
Tailored Treatment Strategies in First Line Therapy for Ovarian Cancer Patients: A Critical Review of the Literature 49
Validation of REM score to predict endometrial cancer in patients with ultrasound endometrial abnormalities: results of a new independent dataset 49
Surgical treatment of rectovaginal endometriosis with extensive vaginal infiltration: results of a systematic three-step vagino-laparoscopic approach 49
Tailoring parametrectomy for early cervical cancer (Stage IA-IIA FIGO): a review on surgical, oncologic outcome and sexual function 49
The role of macroplastique implantation in the management of occult urinary stress incontinence 49
Hormone replacement therapy in cancer survivors: Utopia? 48
Update on urodynamic bladder dysfunctions after radical hysterectomy for cervical cancer 48
Use of liposome encapsulated doxorubicin citrate (LEDC) as a valid drug in patients affected by ovarian cancer suffering from chemotherapy side-effects 48
Post-radical hysterectomy detrusor dysfunctions: is sacral neurostimulation a valid treatment strategy? 47
Neoadjuvant chemotherapy plus radical surgery followed by chemotherapy in locally advanced cervical cancer 45
Learning curves of a resident surgeon performing transobturator tape procedures for stress urinary incontinence 45
ECONOMIC IMPACT AMONG FAMILY CAREGIVERS OF ADVANCED OVARIAN CANCER PATIENTS 44
The role of human epididymis protein 4 as a biomarker in gynecologic malignancies 44
Total rectosigmoidectomy versus partial rectal resection in primary debulking surgery for advanced ovarian cancer 43
Quality of life in patients with endometrial cancer treated with or without systematic lymphadenectomy 42
Vaginectomy as treatment of isolated vaginal relapse (IVR) of gynecological neoplasms 42
The novel biomarker HE4 versus CA125 in detecting endometrial cancer: A case control prospective study 41
Use of Sensor Array Analysis to Detect Ovarian Cancer through Breath, Urine, and Blood: A Case-Control Study 40
Suburethral sling in autoimmune patients: complications, quality of life, and success rate 40
Use of carboplatinum as neoadjuvant setting for patients affected by locally advanced cervical cancer 39
Success rates, quality of life, and feasibility of sacral nerve stimulation in elderly patients: 1-year follow-up 37
Reply from Authors re: Elisabetta Costantini, Massimo Lazzeri. Elephants Can Remember. Eur Urol 2010;58: 678-9 37
Surgical primary treatment of stage IVA cervical cancer: A multicenter retrospective study. 37
QUALITY OF LIFE IN PLATINUM-SENSITIVE RECURRENT OVARIAN CANCER: CHEMOTHERAPY VERSUS SURGERY PLUS CHEMOTHERAPY 37
Use of carboplatinum as neoadjuvant setting for patients affected by locally advanced cervical cancer 35
IGCS Intraoperative Technology Taskforce. Update on near infrared imaging technology: beyond white light and the naked eye, indocyanine green and near infrared technology in the treatment of gynecologic cancers 35
Totale 8.318
Categoria #
all - tutte 49.191
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.191


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022131 0 0 9 0 0 0 0 4 1 4 0 113
2022/202345 0 1 1 0 1 1 10 2 2 3 16 8
2023/2024443 14 39 28 36 36 137 5 60 8 13 34 33
2024/20254.104 78 22 118 27 25 90 62 37 228 265 1.429 1.723
2025/20263.123 266 142 125 268 161 190 880 198 295 333 136 129
2026/2027472 59 316 97 0 0 0 0 0 0 0 0 0
Totale 8.318